文献速递血栓与止血

血友病A疼痛机制小鼠模型的建立与特征分析

Characterization of a mouse model to study mechanisms of hemophilia A pain.
PubMed 文献 · Blood Adv · 2026-01-01

研究在因子VIII敲除小鼠中建立急性和慢性疼痛模型,模拟关节积血疼痛与步态改变。亚髌骨损伤后4天出现伤害防御行为增加、机械性和深部组织痛觉过敏、负重受损及步态改变,持续至8周;10周龄未损伤小鼠也出现类似改变,提示慢性疼痛。关节积血诱导全身炎症标志物升高和关节局部炎症介质增加,重组FVIII治疗仅部分改善疼痛行为。

要点

  • FVIII敲除小鼠亚髌骨损伤后4天出现痛觉过敏和步态改变,持续8周。
  • 10周龄未损伤FVIII敲除小鼠也出现疼痛行为,提示慢性疼痛。
  • 关节积血诱导全身和关节局部炎症介质升高,重组FVIII仅部分改善疼痛。

核心结论

  • 血友病A小鼠模型可模拟关节积血相关急性和慢性疼痛及步态改变,疼痛机制涉及炎症和血管变化。
  • 当前血友病A治疗后疼痛可能持续存在。

研究设计与样本

  • 使用因子VIII敲除小鼠(B6;129S-FVIIItm1Kaz/J)建立急性膝损伤模型和慢性疼痛模型。
  • 评估伤害防御行为、机械性和深部组织痛觉过敏、负重和步态,并检测血清和关节局部炎症介质。

主要发现

  • 亚髌骨损伤后4天出现伤害防御行为增加、机械性和深部组织痛觉过敏、负重受损和步态改变,持续至8周。
  • 10周龄未损伤FVIII敲除小鼠出现类似行为和步态改变。
  • 关节积血诱导血清淀粉样蛋白P和白细胞介素-6显著升高,损伤膝关节中中性粒细胞弹性蛋白酶、髓过氧化物酶、肥大细胞脱颗粒、P物质和降钙素基因相关肽显著增加。
  • 重组FVIII治疗部分改善疼痛行为。

临床怎么用

  • 该模型可用于研究血友病A疼痛机制和步态改变,有助于开发疼痛治疗靶点。
  • 血友病A患者疼痛管理需关注当前治疗后疼痛可能持续存在。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Pain is a debilitating feature of hemophilia A (HA), yet it remains understudied. We developed models of chronic and acute pain in factor VIII knockout (FVIIIKO; B6;129S-FVIIItm1Kaz/J) mice, demonstrating characteristic features of hemarthrosis pain and gait. Using these models, we examined the mechanisms involving inflammation and vascular changes triggered by bleeding to produce pain. To recapitulate hemarthrosis, we used an acute knee-injury model to assess acute pain. We observed an increase in nocifensive behaviors, mechanical and deep tissue hyperalgesia, impaired weight bearing, and gait changes 4 days after subpatellar injury, which persisted through 8 weeks. The uninjured FVIIIKO mice showed similar changes in behaviors and gait at 10 weeks of age, suggestive of chronic pain. Dynamic gait changes indicated compensatory behavior. Hemarthropathy induced a significant elevation in circulating serum amyloid P and interleukin-6, and the injured knee joint showed a significant increase in neutrophil elastase, myeloperoxidase, mast cell degranulation, substance P (SP), and calcitonin gene-related peptide (CGRP), suggestive of global inflammation. SP and CGRP stimulate vascular permeability and arteriolar dilatation, respectively, but are also involved in the generation and maintenance of pain. Mast cell tryptase and neutrophil elastase activate protease-activated receptor 2, which causes nociceptor activation, leading to pain. Recombinant FVIII treatment led to partial improvement in pain behaviors. Thus, pain may persist after current HA treatments. Our study shows that a mouse model of HA can be used to study the mechanisms of pain and gait, which will enable us to develop treatable targets for pain in HA.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Fouda R, Argueta D, Goel Y, et al. Characterization of a mouse model to study mechanisms of hemophilia A pain. Blood Adv. 2026. PMID: 42295153. doi:10.1182/bloodadvances.2025019420

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。